EUCTR2010-019843-20-PL进行中（未招募）不适用
A Prospective 3-Year Follow-up Study in Subjects Previously Treated in a Phase IIb or Phase III Study With a TMC435-Containing Regimen for the Treatment of Hepatitis C Virus (HCV) infection
Janssen R&D Ireland0 个研究点目标入组 250 人开始时间: 2010年9月17日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Have previously participated in a Phase II or Phase III study; received at least one dose of TMC435 in that study; completed the last patient visit of the previous study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 35
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 2
排除标准
- •Currently enrolled or plan to enroll in another study with an investigational drug or invasive investigational medical device; received antiviral or immunomodulating treatment for HCV between last visit previous study and this study
研究者
相似试验
进行中（未招募）
1 期
TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.Hepatitis C Virus (HCV)MedDRA version: 16.1Level: LLTClassification code 10019752Term: Hepatitis C virus (HCV)System Organ Class: 100000004848EUCTR2010-019843-20-DEJanssen R&D Ireland250
进行中（未招募）
1 期
A 3-Year Follow-up Study in Subjects previously treated with Odalasvir and AL-335 With or Without Simeprevir for Hepatitis C Virus (HCV) Infection.EUCTR2016-002608-19-PLJanssen-Cilag International NV54
进行中（未招募）
1 期
A 3-Year Follow-up Study in Subjects previously treated with Odalasvir and AL-335 With or Without Simeprevir for Hepatitis C Virus (HCV) Infection.Chronic Hepatitis C virus infection.MedDRA version: 19.1 Level: PT Classification code 10019744 Term: Hepatitis C System Organ Class: 10021881 - Infections and infestationsEUCTR2016-002608-19-DEJanssen-Cilag International NV54
进行中（未招募）
1 期
A 3-Year Follow-up Study in Subjects previously treated with Odalasvir and AL-335 With or Without Simeprevir for Hepatitis C Virus (HCV) Infection.Chronic Hepatitis C virus infection.MedDRA version: 19.1Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-002608-19-ESJanssen-Cilag International NV250
进行中（未招募）
1 期
A 3-Year Follow-up Study in Subjects previously treated with Odalasvir and AL-335 With or Without Simeprevir for Hepatitis C Virus (HCV) Infection.Chronic Hepatitis C virus infection.MedDRA version: 19.1Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-002608-19-BEJanssen-Cilag International NV250